the method is sufficiently sensitive for pharmacokinetic study of furosemide with normal subjects and patients with liver cirrhosis and/or renal disease after oral administration of furosemide in a retard capsule , and for study of protein binding of furosemide in patients with various diseases .
C0023890
liver cirrhosis
C0016860
furosemide